Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer.
Cancer Cell Int
; 22(1): 82, 2022 Feb 15.
Article
en En
| MEDLINE
| ID: mdl-35168603
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Guideline
Idioma:
En
Revista:
Cancer Cell Int
Año:
2022
Tipo del documento:
Article